跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lupilan - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lupilan
Approved
STANDARD
Lupilan
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
75c73018fcc20503
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
75c73018fcc20503
Drug Approval Philippines Name
Lupilan
Product Name
Lupilan
Registration Number
DRP-8536-02
Brand Name
Lupilan
Generic Name
Olanzapine
Dosage Form
Orally Disintegrating Tablet
Dosage Strength
5 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Multicare Pharmaceuticals Phils. Inc
Issuance Date
29 March 2024
Expiry Date
31 October 2029
Pharmacologic Category
Antipsychotic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
75c73018fcc20503
Type
Standard
Back to Philippines FDA Approvals